gabapentin and avapro
gabapentin has been researched along with avapro in 7 studies
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Mao, Y; Thompson, MJ; Tsai, EW; Wang, Q | 1 |
Chen, YL; Hsu, CH; Lau, SC; Liu, IC; Pei, D; Yu, SM | 1 |
Reviews
1 review(s) available for gabapentin and avapro
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
6 other study(ies) available for gabapentin and avapro
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Quantitation of poloxamers in pharmaceutical formulations using size exclusion chromatography and colorimetric methods.
Topics: Amines; Biphenyl Compounds; Chromatography, Gel; Colorimetry; Cyclohexanecarboxylic Acids; Ephedrine; Gabapentin; gamma-Aminobutyric Acid; Irbesartan; Molecular Structure; Poloxamer; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tetrazoles | 2004 |
Restless legs syndrome/Willis-Ekbom disease in type 2 diabetes as the initial manifestation of Parkinson's disease and major cardiovascular disease.
Topics: Aged; Amines; Analgesics; Anticonvulsants; Antihypertensive Agents; Antiparkinson Agents; Aspirin; Biphenyl Compounds; Carotid Stenosis; Clonazepam; Coronary Artery Disease; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypertension; Irbesartan; Male; Parkinson Disease; Quality of Life; Restless Legs Syndrome; Sleep; Tetrazoles; Treatment Outcome | 2017 |